Arenicin-3 [G1,12A; Y5N; Y17H], N2

General Information


DRACP ID  DRACP03810

Peptide Name   Arenicin-3 [G1,12A; Y5N; Y17H], N2

Sequence  AFCWNVCVYRNAVRVCHRRCN

Sequence Length  21

UniProt ID  A0A3F2YLM5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  5Y0J 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C109H169N39O26S4

Absent amino acids  DEGIKLMPQST

Common amino acids  CRV

Mass  292695

Pl  9.08

Basic residues  5

Acidic residues  0

Hydrophobic residues  8

Net charge  5

Boman Index  -5419

Hydrophobicity  -3.33

Aliphatic Index  64.76

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  7240

Absorbance 280nm  362

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29329001

Title  Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11

Doi Not available

Year  2018

Literature 2

Pubmed ID 28611436

Title  Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12811

DRACP is developed by Dr.Zheng's team.